Affiliated Tumor Hospital of Xinjiang Medical University

Ürümqi, Xinjiang 830002

0 studies enrolling now · 2 studies all time

What they study most

Chronic Lymphocytic Leukemia, Lymphoma, Mantle-Cell, Small Lymphocytic Lymphoma

Studies at this site

• Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) — Running, not enrolling
• Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling